| Macrophages are alternatively activated in patients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease M Bacci, A Capobianco, A Monno, L Cottone, F Di Puppo, B Camisa, ... The American journal of pathology 175 (2), 547-556, 2009 | 461 | 2009 |
| Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy F Pastorino, C Brignole, D Marimpietri, M Cilli, C Gambini, D Ribatti, ... Cancer research 63 (21), 7400-7409, 2003 | 406 | 2003 |
| Targeting liposomal chemotherapy via both tumor cell–specific and tumor vasculature–specific ligands potentiates therapeutic efficacy F Pastorino, C Brignole, D Di Paolo, B Nico, A Pezzolo, D Marimpietri, ... Cancer research 66 (20), 10073-10082, 2006 | 294 | 2006 |
| The person-to-person transmission landscape of the gut and oral microbiomes M Valles-Colomer, A Blanco-Míguez, P Manghi, F Asnicar, L Dubois, ... Nature 614 (7946), 125-135, 2023 | 293 | 2023 |
| Expression of ΔNp73 is a molecular marker for adverse outcome in neuroblastoma patients I Casciano, K Mazzocco, L Boni, G Pagnan, B Banelli, G Allemanni, ... Cell Death & Differentiation 9 (3), 246-251, 2002 | 265 | 2002 |
| Differential Effects of N-(4-Hydroxyphenyl)retinamide and Retinoic Acid on Neuroblastoma Cells: Apoptosis versus Differentiation M Ponzoni, P Bocca, V Chiesa, A Decensi, V Pistoia, L Raffaghello, ... Cancer research 55 (4), 853-861, 1995 | 265 | 1995 |
| Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma A Garaventa, R Luksch, MSL Piccolo, E Cavadini, PG Montaldo, ... Clinical Cancer Research 9 (6), 2032-2039, 2003 | 228 | 2003 |
| Doxorubicin-loaded Fab′ fragments of anti-disialoganglioside immunoliposomes selectively inhibit the growth and dissemination of human neuroblastoma in nude mice F Pastorino, C Brignole, D Marimpietri, P Sapra, EH Moase, TM Allen, ... Cancer research 63 (1), 86-92, 2003 | 215 | 2003 |
| Antiproliferative and pro-apoptotic activity of eugenol-related biphenyls on malignant melanoma cells M Pisano, G Pagnan, M Loi, ME Mura, MG Tilocca, G Palmieri, D Fabbri, ... Molecular cancer 6, 1-12, 2007 | 180 | 2007 |
| Targeting macrophages as a potential therapeutic intervention: impact on inflammatory diseases and cancer M Ponzoni, F Pastorino, D Di Paolo, P Perri, C Brignole International journal of molecular sciences 19 (7), 1953, 2018 | 171 | 2018 |
| Effect of bortezomib on human neuroblastoma cell growth, apoptosis, and angiogenesis C Brignole, D Marimpietri, F Pastorino, B Nico, D Di Paolo, M Cioni, ... Journal of the National Cancer Institute 98 (16), 1142-1157, 2006 | 163 | 2006 |
| Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients M Semeraro, S Rusakiewicz, V Minard-Colin, NF Delahaye, D Enot, ... Science translational medicine 7 (283), 283ra55-283ra55, 2015 | 161 | 2015 |
| Spot overlapping in two‐dimensional maps: a serious problem ignored for much too long N Campostrini, LB Areces, J Rappsilber, MC Pietrogrande, F Dondi, ... Proteomics 5 (9), 2385-2395, 2005 | 158 | 2005 |
| Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD2-targeted immunoliposomes: antitumor effects G Pagnan, DD Stuart, F Pastorino, L Raffaghello, PG Montaldo, TM Allen, ... Journal of the National Cancer Institute 92 (3), 253-261, 2000 | 148 | 2000 |
| Targeted drug delivery and penetration into solid tumors A Corti, F Pastorino, F Curnis, W Arap, M Ponzoni, R Pasqualini Medicinal research reviews 32 (5), 1078-1091, 2012 | 136 | 2012 |
| Recent advances in the developmental origin of neuroblastoma: an overview M Ponzoni, T Bachetti, MV Corrias, C Brignole, F Pastorino, E Calarco, ... Journal of Experimental & Clinical Cancer Research 41 (1), 92, 2022 | 135 | 2022 |
| Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models F Pastorino, C Brignole, D Marimpietri, G Pagnan, A Morando, D Ribatti, ... Clinical cancer research 9 (12), 4595-4605, 2003 | 116 | 2003 |
| A novel liposomal Clodronate depletes tumor-associated macrophages in primary and metastatic melanoma: Anti-angiogenic and anti-tumor effects F Piaggio, V Kondylis, F Pastorino, D Di Paolo, P Perri, I Cossu, F Schorn, ... Journal of Controlled Release 223, 165-177, 2016 | 113 | 2016 |
| Tumor vascular targeting with tumor necrosis factor α and chemotherapeutic drugs A Corti, M Ponzoni Annals of the New York Academy of Sciences 1028 (1), 104-112, 2004 | 113 | 2004 |
| Enhanced antitumor efficacy of clinical-grade vasculature-targeted liposomal doxorubicin F Pastorino, D Di Paolo, F Piccardi, B Nico, D Ribatti, A Daga, G Baio, ... Clinical Cancer Research 14 (22), 7320-7329, 2008 | 112 | 2008 |
Michele CilliOspedale Policlinico San Martino - Genova - ITEmail yang diverifikasi di hsanmartino.it
